Wild Bioscience
PrivateLast Round
Series A
Jul 31, 2026
Total Funding Raised
$151.88M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Wild Bioscience operates in Healthcare & Life Sciences and is based in Abingdon. Its latest recorded funding round was a Series A round in July 2026.
Wild Bioscience is an agritech company that develops high-yielding, climate-resilient crop varieties by using machine learning and plant biology to identify beneficial traits in wild plants.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Wild Bioscience Comparables
Compare Wild Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Phytoform Labs | 84% | |
| The Traits Company | 84% | |
| OlsAro | 83% |
For institutional investors. Book with your work email.
Wild Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 31, 2026 | ||||
| Series A | Oct 16, 2025 | ||||
| Grant | Jul 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Wild Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Braavos Investment Advisers | Series A, Seed |
| Oxford Science Enterprises | Series A, Seed |
| University of Oxford | Series A |
| Innovate UK | Seed |
| Oxford Science Enterprises | Series A |
| Braavos Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 31, 2026
$75M round led by Ellison Institute of Technology.
- Jan 1, 2026
Company is a spin-out from Oxford University.
For institutional investors. Book with your work email.
Wild Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Wild Bioscience's valuation, stock price, and market status.
Is Wild Bioscience a public or private company?
Wild Bioscience is a private company.
What is the current stock price of Wild Bioscience?
Wild Bioscience is a private company, so its shares have no public market price. Caplight tracks Wild Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Wild Bioscience worth (valuation)?
Valuation information for Wild Bioscience is not publicly available.
Can I buy Wild Bioscience stock?
Wild Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Wild Bioscience's last funding round?
Wild Bioscience's most recent funding round was Series A on July 31, 2026.
Who are the main investors in Wild Bioscience?
Key investors in Wild Bioscience include Innovate UK, Braavos Investment Advisers, Oxford Science Enterprises, Ellison Institute of Technology.
Will Wild Bioscience IPO soon?
No public IPO plans have been announced for Wild Bioscience.
How can I track Wild Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Wild Bioscience's shares on secondary markets.